Professional Documents
Culture Documents
Screening and Diagnostic Tests
Screening and Diagnostic Tests
Screening and Diagnostic Tests
First trimester screening is a combination of fetal ultrasound and maternal blood testing. It can help
find out the risk that the fetus has certain birth defects. Screening tests may be used alone or with
other tests.
These tests measure 2 substances found in the blood of all pregnant women:
• Human chorionic gonadotropin (hCG). This is a hormone made by the placenta in early
pregnancy. Abnormal levels are linked to a higher risk for chromosome problems.
When used together, these tests have a greater ability to find out if the fetus might have a genetic
birth defect such as Down syndrome (trisomy 21) and trisomy 18.
If the results of these tests are abnormal, your healthcare provider will suggest genetic counseling.
You may need more testing. That may include chorionic villus sampling, amniocentesis, cell-free
fetal DNA, or other ultrasounds.
Copyright ©2020 Email add: dcasquejo@hnu.edu.ph
dcasquejo@hnu.edu.ph
Abnormal results of AFP and other markers may mean you need more testing.
An ultrasound is often done to confirm the dates of the pregnancy. It also looks
at the fetal spine and other body parts for problems. You may need an
amniocentesis for accurate diagnosis.
What is an amniocentesis?
An amniocentesis is a test that takes a small sample
of the amniotic fluid. It is done to diagnose
chromosome problems and open neural tube
defects (ONTDs) such as spina bifida. The test can
also look for other genetic problems and disorders if
you have a family history of them. These other
results also depend on the lab doing the testing. An
amniocentesis is generally offered to women
between the 15th and 20th weeks of pregnancy who
are at higher risk for chromosome problems. This
includes women who have had an abnormal
maternal blood screening test. The test may have
indicated a higher risk for a chromosome problem or
neural tube defect.
An amniocentesis involves putting a long, thin needle through your abdomen into the
amniotic sac. The healthcare provider withdraws a small sample of the amniotic fluid. The
amniotic fluid has cells shed by the fetus,. These cells have genetic information. The
specific details of each test vary slightly, but an amniocentesis often follows this process:
After the test, the woman should avoid any strenuous activity for 24 hours. She may feel
some cramping during or after the amniocentesis.
If the woman is carrying twins or other multiples, she will need sampling from each
amniotic sac to study each baby.
The fluid sample is sent to a genetics lab so that the cells can grow and be tested. AFP is
also measured to rule out an open neural tube defect such as spina bifida. AFP is a protein
made by the fetus and is in the fluid.
Results are often available in 10 days to 2 weeks, depending on the lab.
CVS may be offered if the woman is at higher risk for chromosome problems. She may also be
offered it if she has a family history of a genetic problem that is testable from the placental tissue.
CVS is usually done between the 10th and 13th weeks of pregnancy. The exact method for CVS
can vary, but the procedure involves putting a small tube (catheter) through the vagina and into
the cervix. It usually follows this process:
• The healthcare provider uses ultrasound to guide the catheter into place near the placenta.
• The provider removes tissue using a syringe on the other end of the catheter.
• For a trans-abdominal CVS, the provider puts a needle through the abdomen and into the
uterus to take a sample of cells from the placenta.
• The woman may feel some cramping during and after the CVS procedure.
If the woman is carrying twins or other multiples, she often will need sampling from each
placenta. But CVS is not always advised for multiples because the procedure is complicated
and the placentas may not be in a good position to get a sample.
The tissue samples are sent to a genetic lab to grow and be tested. Results are often
available in 10 days to 2 weeks, depending on the lab.
Some women may not be candidates for CVS, or they may not get results that are 100%
accurate. They may need a follow-up amniocentesis. In some cases an active vaginal
infection such as herpes or gonorrhea will prohibit the procedure. Other times the healthcare
provider takes a sample that does not have enough tissue to grow in the lab. That may
cause incomplete or inconclusive results.
The most basic type of fetal heart rate monitor is to use a type of stethoscope called a fetoscope. Another type
of monitoring is with a hand-held Doppler device. This is often used during prenatal visits to count the fetal heart
rate. During labor, continuous electronic fetal monitoring is often used. The specific details may vary slightly, but
electronic fetal monitoring often follows this process:
• The healthcare provider puts gel on the abdomen to help the ultrasound transducer work properly.
• The provider attaches the ultrasound transducer to the abdomen with straps and sends the fetal heartbeat to a
recorder. The fetal heart rate is displayed on a screen and may be printed onto special paper.
• During contractions, a monitoring device (external tocodynamometer) is placed over the top of the uterus with
a belt. This device can record the patterns of contractions.
Sometimes, internal fetal monitoring is needed for a more accurate reading of the fetal heart rate. This
monitoring can be done when birth is close. The amniotic sac must be broken and the cervix must be partially
dilated to do it. Internal fetal monitoring involves putting an electrode through the dilated cervix. The electrode is
attached to the scalp of the fetus.
The glucose tolerance test is done if the woman has an elevated 1-hour glucose challenge test.
The specific details may vary slightly, but a glucose tolerance test often follows this process:
• The woman may be asked to drink only water on the day of the test.
• The healthcare provider will draw a fasting sample of blood from a vein.
• The woman will be given a special glucose solution to drink.
• The provider will draw blood several times over several hours to measure the glucose levels
in the woman’s body.
Group B streptococcus (GBS) are bacteria found in the lower genital tract of about 1 in 4 women. GBS
infection often causes no problems in women before pregnancy. But it can cause serious illness in the
mother during pregnancy. GBS may cause chorioamnionitis. This is a severe infection of the placental
tissues. It can also cause postpartum infection. Urinary tract infections caused by GBS can lead to preterm
labor and birth, or pyelonephritis and sepsis.
GBS is the most common cause of life-threatening infections in newborns, including pneumonia and
meningitis. Newborn babies get the infection during pregnancy or from the mother's genital tract during labor
and birth.
The CDC advises that all pregnant women be screened for vaginal and rectal group B strep between 35 to
37 weeks gestation. If she has certain risk factors or a positive result, she should be treated with antibiotics.
This will lower the risk of passing GBS to her baby. Babies whose mothers get antibiotics for a positive GBS
test are 20 times less likely to develop the disease than those whose mothers don't get treatment.
What is an ultrasound?
An ultrasound scan is a test that uses
high-frequency sound waves to make
pictures of the internal organs. A
screening ultrasound is sometimes done
during a pregnancy to check normal
fetal growth and make sure of the due
date. Ultrasounds may be done at
various times throughout pregnancy for
many reasons.
Third trimester
Many genetic problems can be diagnosed before birth. The healthcare provider or midwife
may advise genetic testing during the pregnancy if the woman or her partner has a family
history of genetic disorders or if she has had a fetus or baby with a genetic problem.
Examples of genetic disorders that are commonly screened for include:
• Cystic fibrosis
• Spinal muscular dystrophy
• Fragile X
• Thalassemia
• Sickle cell anemia
• Tay-Sachs disease
Very low or high hemoglobin levels are associated with increase fetal risk.
Gestational age should be taken into account when assessing hemoglobin, as
levels decrease during pregnancy due to hemo dilution caused by increase
plasma volume.
ANSWERS:
1. ULTRASOUND 5. ULTRASOUND
2. OGCT/OGTT 6.FETAL SCREENING
3. GENETIC SCREENING 7. ULTRASOUND
4. AMNIOCENTESIS 8. URINARY ANALYSIS